explore -WSS

explore

author：focus 2025-08-12 09:09:43 - browse：8934

Adam's take main illustration — Molly Ferguson/STAT

Roivant Sciences’ Matt Gline might be this year’s best biopharma CEO, and other thoughts about Monday’s blockbuster deal with Roche — like, why the heck did Roivant’s stock trade down?

Gline created $5 billion from $50 million — in less than one year.Regular readers know that every December, I choose a best biopharma CEO. It’s a subjective award, but deal-making acumen, management skills, and delivering shareholder value are important measuring sticks. It’s still too early to call this year’s contest, but Gline is a front-runner.

Last December, Roivant essentially acquired an experimental treatment for inflammatory bowel disease called RVT-3101 from Pfizer for $45 million and then spent another $5 million to position the drug for future Phase 3 studies. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： The strange history of BMI, the body mass index

hotspot

WSS

Medical experts exlpore how to eliminate bias in clinical algorithms

How to ethically and practically extend health care to all

Why do we get seasonal allergies?

Belarusian journalist sentenced to 4 years in prison as crackdown continues

How I helped Pfizer think through the ethics of Viagra

Florida officials tell state schools to teach AP Psychology 'in its entirety'

leisure time

explore

hotspot

Heart attack and stroke risk calculators need revising

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Medicare proposal to cover medical devices draws a mixed reaction

Pharma showers House GOP doctor with campaign cash

DIEP, the 'gold standard' of breast reconstruction, is under threat

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Alnylam reports growth in sales of rare disease treatments

Jerome Adams on the need for new antivirals for Covid

Florida officials tell state schools to teach AP Psychology 'in its entirety'

knowledge

FDA approves Sage Therapeutics’ rapid

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Medical experts exlpore how to eliminate bias in clinical algorithms

Illumina to lay off 10% of research and development team

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

Alnylam reports growth in sales of rare disease treatments

knowledge

hotspot

Wikipedia

explore